Genome-wide association (GWA) studies have been limited by the reliance on common variants present on microarrays or imputable from the HapMap Project data. More recently, the completion of the 1000 Genomes Project has provided variant and haplotype information for several million variants derived from sequencing over 1,000 individuals. To help understand the extent to which more variants (including low frequency (1% # MAF ,5%) and rare variants (,1%)) can enhance previously identified associations and identify novel loci, we selected 93 quantitative circulating factors where data was available from the InCHIANTI population study. These phenotypes included cytokines, binding proteins, hormones, vitamins and ions. We selected these phenotypes because many have known strong genetic associations and are potentially important to help understand disease processes. We performed a genome-wide scan for these 93 phenotypes in InCHIANTI. We identified 21 signals and 33 signals that reached P,5610
Introduction
Genome-wide association (GWA) studies have identified many novel associations between common genetic variants and human traits. These studies capture a large proportion of SNP-based common variation in the human genome but are less efficient at capturing low frequency and rare variants.
Imputation is the process of inferring missing data based on known data [1] . Imputation is useful for performing GWA metaanalyses across studies with the same traits but different genotyping arrays. Imputation can also potentially identify signals of association not detected by direct genotypes. In the simplest scenario, a causal variant, or the most strongly associated genetic variant, may not be directly genotyped and may exist on a haplotype that is optimally captured by two rather than one directly genotyped SNP ( Figure 1 ).
There are now two main sources of reference genotypes for imputation of missing variants. The International HapMap Project Phases 1 to 3 [2] [3] [4] [5] consists of 4.1 million directly genotyped SNPs in 1,486 individuals and has facilitated the imputation of approximately 2.5 million SNPs in standard GWA studies. More recently, the 1000 Genomes Project has completed the low-pass sequencing of the whole genome from 1,094 individuals from a range of ethnic groups [6] . The project has annotated .37 million variants. The sequencing based approach and the large number of individuals means these variants include many low frequency (1% # MAF ,5%) and rare (MAF,1%) variants.
In this study we tested the hypothesis that imputation of variants identified by the 1000 Genomes Project (including low frequency and rare variants) would enhance previously identified associations and identify novel associations. We selected 93 traits measured in ,1,200 individuals in the InCHIANTI study ( Table 1 and   Table S1 ). All traits were continuous measures of circulating factors [7] , [8] . These traits included circulating lipids, proteins, ions and vitamins and were selected for two reasons. First, for many traits, strong genetic associations have previously been observed in relatively small sample sizes, and so we potentially had good power to detect novel effects and stronger signals at known loci. These signals include those far exceeding genome-wide significance in our dataset alone and therefore offer a good opportunity to assess whether or not 1000 Genomes imputation can improve and refine known associations. Second, identifying genetic associations with circulating factors is potentially important to help understand disease processes. Many circulating factors are altered in disease cases compared to controls, but it is rarely understood if these factors are causal, confounded or secondary to disease processes. Genetic variants can be used to help identify causal pathways using Mendelian randomisation [9] [10] [11] [12] .
Results

Variation captured by HapMap and 1000 Genomes
After applying quality control metrics we captured 2,493,682 and 10,879,115 SNPs from HapMap (release 22) and 1000 Genomes imputation (November 2010, Phase1-a), respectively (Table S2, Figure S1 ).
The 1000 Genomes based imputation captured many more variants at high quality (defined as r in the NHGRI catalogue or in other published GWA studies with the same or very similar trait.
A further 3 signals were classified as known signals but with different traits. A signal near the HPR gene was associated with alpha-2 globulin and was previously reported as associated with haptoglobulin. A signal near the APOB gene was associated with oxidized LDL and was previously associated with HDL and triglycerides, and a signal near the SUGP1 gene was associated with vitamin E and was previously associated with LDL cholesterol, total cholesterol and triglycerides.
Of the remaining 4 signals, 3 were putative novel associations ( Table 2) , and one was an association with hsCRP and represented a previously known locus -our index SNP was correlated with an r 2 of 0.32 with a published hsCRP associated variant (rs876537 [13] ) ,7 kb upstream of the CRP gene. Figure 3 and Known and putative novel signals identified by 1000 Genomes that were missed by imputation with Hapmap
For the 13 signals detected by the 1000 Genomes imputation but not by the HapMap imputation analysis, we calculated linkage disequilibrium between the index 1000 Genomes SNP and the most strongly associated HapMap SNPs within a 2 Mb window centred on the 1000 Genomes SNP ( GC = genomic control factor used to adjust P-value, Chr = chromosome, BP (b37) = human genome build 37 base pair position, SNP = index SNP representing signal, MAF = minor allele frequency, P* = P-value derived after applying genomic control. Annotations refer to whether associations represent known (present in NHGRI catalogue at P,5610 28 or GWAS literature) signals for same trait, different traits or represent putative novel signals. doi:10.1371/journal.pone.0064343.t002
appeared to represent signals specifically detected by 1000 Genomes imputation. These seven signals had very low correlations (r 2 ,0.05) with the most strongly associated HapMap SNP ( Table 5) . Six of these seven signals represented putative low frequency -large effect variants, with minor allele frequencies # 0.02 and per allele effect sizes of 1.1 -2.1 standard deviations (SDs). We therefore examined these loci in more detail. We checked imputed dosages and trait values for the small number of heterozygous individuals that were driving these associations, but found no obvious sources of error ( Figure S2 ). All but one of these 7 signals had a proxy SNP that also showed strong evidence of association, even if the association did not reach P,5610
28 .
Does 1000 Genomes imputation identify stronger associations at loci identified by HapMap based imputation?
We identified 14 loci associated with 13 traits where both the HapMap and 1000 Genomes index SNPs were P,5610
28 and differed from each other ( Table 4 and Table 6 ). In the multivariable SNP analyses that included the two SNPs at each locus against the relevant phenotype, the 1000 Genomes SNP was more strongly associated in 13 of 14 loci (one-tail Binomial P = 0.0009). The P-value improvements were marginal for 8 of these associations and the 1000 genomes signal was not statistically stronger, but 5 of the 14 associations, showed evidence of stronger signals at P,0.05 and three at P,0.01, Table 6 ). 
Replication and validation
For three of the putative novel associations we attempted to replicate associations in additional data. We used 476 and 529 individuals from the BLSA study to test associations with TNFalpha and vitamin B12, respectively, and 232, 1554 and 406 individuals from the TwinsUK study to test associations with TNF-alpha, vitamin B12 and Cl 2 , respectively. We did not find any evidence of association. However, one of the putative novel variants does represent a real association. On closer inspection of the literature and comparison of linkage disequilibrium statistics we showed that the SNP rs112635299 represents the known signal between an amino acid changing variant in the SERPINA gene and alpha-1-globulin [14] . This signal is present in our data at 0.007 MAF, is a strong risk factor for the lung disease emphysema and was missed by imputation of HapMap genotypes (the SNP identified is not present in the HapMap reference panel, best Pvalue in the region 2610 24 ) ( Table 7 and Figure 5 ).
Discussion
Our results show that imputation of genotype data from the sequenced based 1000 Genomes reference panel successfully captures many more variants than imputation of genotype data from the microarray based HapMap reference panel. As expected, this increase in variants captured was much greater for low frequency and rare SNPs compared to common SNPs.
The main purpose of our study was to assess how imputation of missing genotypes from the sequenced based 1000 Genomes reference panel improves our ability to detect genotype-phenotype associations compared to the microarray-genotype based HapMap reference panel. Our results provide two main conclusions. First, that imputation of 1000 Genomes genotype data marginally improves the strength of association signals at known loci. Of 20 associations detected at P,5610 28 in both analyses (17 of which represent well replicated signals in the NHGRI catalogue), six were captured by the same index SNP, five were more strongly associated in 1000 Genomes imputed data and one was nominally more strongly associated in HapMap imputed data (based on multivariable statistics Table 6 ). This result was not surprising given that most known associations involve common variants that are likely to be well imputed by both reference datasets. Nevertheless, it is possible that associations undetected by HapMap can be appreciably stronger when using 1000 Genomes imputation, as previously reported in cis-eQTL data [15] . We also detected previously unreported associations between known signals and traits. The signals between variants near SUGP1/ TM6SF2 and vitamin E and APOB and oxidised LDL were both previously reported with triglycerides and LDL cholesterol. Vitamin E is a lipid-soluble vitamin and associations between lipid variants and vitamin levels have been described before [16] .
The second main conclusion is that imputation from 1000 Genomes data can detect associations between low frequency variants and phenotypes that were previously missed by HapMap based imputation approaches. The association between rs112635299 and alpha-1 globulin (%) near the SERPINA gene represents the same signal as that detected between rs28929474 Advances Using 1000 Genomes Imputation over HapMap PLOS ONE | www.plosone.org(MAF = 0.007; r 2 = 0.88) and alpha1-antitrypsin that predisposes to emphysema [14] . Although previously known, this association provides important proof of principle that 1000 Genomes imputation can detect novel, low frequency-large effect associations, and potentially save costs of sequencing within studies. One additional association reached our stricter cut-off of P,5610 211 in 1000 Genomes based imputation that was not previously reported. Although we have no replication data, the signal between rs113341849 near the CCR1 and CCR2 genes and Macrophage inflammatory protein-1b is likely to be real given that these genes encode the receptors to which the MIP1b proteins bind.
A third point emerging from our data is that the selection of appropriate statistical thresholds is important when testing more than one trait and many more variants. Of three putative lowfrequency-large effect signals we were able to follow up in additional samples none showed evidence of replication. We note that 7 of the 8 putative low frequency-large effect novel associations identified in the 1000 Genomes based data did not reach our stricter cut-off of P,5610
211 , and suspect that most represent false positives due to multiple testing.
The main strength of our study was that we tested a large number of circulating biomarkers. Of these phenotypes, 20 had known signals for the same trait, detectable at genome-wide significance in our single study of 1210 individuals. This large number of phenotypes allowed us to test the extent to which 1000 Genomes imputation enhances known association signals. One limitation to our study is the relatively small sample size. Imputation from the 1000 Genomes reference panel may be more beneficial for strengthening associations at known loci in larger sample sizes. Nevertheless, although we only used 1210 individuals, 7 of the known signals were associated at P,5610 212 and 3 at P,x10
215 , and therefore provided similarly strong association signals to those detected in larger sample sizes for disease traits. A second limitation to our study is that we did not use the very latest version of 1000 genomes and we only tested one method of imputation (MACH). Our study used the version I panel that includes 1094 individuals and 27,713,623 non-singleton SNPs whereas the latest version includes 1092 individuals and 28,681,763 non-singleton SNPs plus indels. Our data therefore provide a lower bound on the gains to be made from 1000 genomes imputation, although a comparison of association statistics for one biomarker and one chromosome with a known strong signal (chromosome 14 and alpha 1 globulin; Figure S3 ) suggests that any improvement from version I to version III will not be large.
In conclusion, imputation of missing genotypes from sequenced based 1000 Genomes reference data can detect novel genotypephenotype associations but may not appreciably enhance known signals.
Methods
Samples
We used DNA from 1,210 individuals from the population based InCHIANTI study; a study of aging from the Chianti region in Tuscany, Italy [7] , [8] (Table 1 ). All summary statistics based association data is available on request from the authors or from the InCHIANTI study door website at http://www. inchiantistudy.net/.
Phenotypes
We selected 93 circulating factors measured in the InCHIANTI study (Table S1 ). These circulating factors included lipids, proteins, (including binding proteins and hormones), vitamins and ions.
Genotyping and Imputation
Genome-wide genotyping was performed using the Illumina Infinium HumanHap550 genotyping chip. Standard quality control procedures were used to exclude individuals with discordant sex and call rates less than 98% and filter out SNPs with MAF ,1%, Hardy Weinberg P,1610
24 and a call rate ,99% [8] . There were no ethnic outliers based on a principle components analysis [8] . This resulted in data from 495,343 directly genotyped SNPs in 1,210 individuals. These 495,343 SNPs were used as the scaffold for HapMap and 1000 Genomes based imputation.
For HapMap based imputation we used MACH 1.0.16 to impute missing genotypes not captured by the Illumina chip. We used the HapMap r22 build-36 reference panel (CEU) and imputed 2,543,887 SNPs. The reference panel comprised of 120 haplotypes from 60 parents of 30 Caucasian trios. Of these 2,543,887 SNPs, we excluded 50,205 that were imputed with an r To perform 1000 Genomes based imputation we estimated phase of contiguous variants in the InCHIANTI subjects using the haplotypes calculated using data from the 1000 Genomes Project consisting of 1,094 individuals and 2,188 haplotypes and the program MACH 1.0.16. We then imputed the variants in the build-37 November 2010 release of 1000 Genomes (Phase 1-a interim) into the phased haplotypes using MINIMAC. This resulted in 37,426,733 imputed SNPs. Of these 37,426,733 SNPs, we excluded 26,547,618 that were imputed with an r 2 imp ,0.5. We used a more stringent cut-off for 1000 Genomes imputation as recommended at time of analysis. This left 10,879,115 SNPs for association analyses. We used a multi-ethnic reference panel that included 381 Europeans (including 98 Tuscans), 181 Americans, 246 Africans and 286 Asians in an attempt to capture variants that may be rare in Europeans but more common on haplotypes from different ethnic backgrounds.
Association analysis
Each phenotype measured at baseline was inverse normalised before age and sex adjusted residuals were generated. A second inverse-normalisation was subsequently applied to the residuals. We ran genome-wide association analysis using MACH2QTL for each trait using both HapMap and 1000 Genomes imputed datasets. We performed a univariable test with dosages representing the index HapMap or index 1000 Genomes SNP as independent variables in an additive genetic model and the normalized residuals of the relevant phenotypes as dependent variables in a linear regression analysis.
Linkage disequilibrium estimates
We estimated linkage disequilibrium within the InCHIANTI data. We used 1000 Genomes imputed dosages (except for two SNPs, where we used HapMap-based dosages because either the SNP was not available in 1000 Genomes imputation reference Table 5 . The 13 signals identified as having an associated 1000 Genomes-based imputed SNP reaching genome-wide significance where the best HapMap SNP did not, ordered by minor allele frequency group (,5% or $5) and the minor allele frequency of the 1000 Genomes SNP. ) and converted to best-guess genotypes. PLINK was then used to obtain linkage disequilibrium estimates of the SNPs of interest within a given locus.
Statistical thresholds
We report associations at two statistical thresholds. First, we used a P-value of 5610 211 to correct the usual threshold of 5610 28 for the ,100 traits analysed and the ,10 fold increase in signals tested (based on 10 million tests arising from 1000 Genomes imputation). This threshold is likely to be conservative given that the 10 million variants are not independent. There is also a Bayesian argument that reasonably presumes that more causal variants exist for more traits and that capturing more variants should result in more true positive signals of association. This argument, combined with the fact that many associations were known means we also report results at the traditional 5610 28 .
Known vs. novel Signals
We downloaded the catalogue of all association signals reaching genome-wide significance (available from the National Human Genome Research Institute (NHGRI), part of National Institutes of Health). We obtained lists of all known SNPs correlated with Table 6 . Results from the univariable and multivariable analysis using the Index HapMap and 1000 Genomes SNPs for 13 traits across 14 loci where both index SNPs were genome-wide significant and differed from each other. .0.8 proxy was associated with the same phenotype or a closely related phenotype (e.g. fatty acids and other lipids) in the NHGRI catalogue (at P,5610 28 ). We classified a locus as known if our index SNP or an r 2 .0.2 and r 2 ,0.8 proxy was associated with the same phenotype in the NHGRI catalogue (P,5610 28 ). As the NHGRI catalogue is not 100% complete, we also conducted literature searches using the name of the circulating factor and other key terms including ''GWAS'' or ''Genome wide''.
Does 1000 Genomes imputation identify stronger associations at loci identified by HapMap based imputation?
For all loci reaching genome-wide significance in the HapMap and 1000 Genomes based analysis we performed additional statistical tests to assess whether or not 1000 Genomes based imputation identifies stronger associations. We performed a multivariable test with dosages representing both the index HapMap and index 1000 Genomes SNP as independent variables (where the two index SNPs were different) in an additive genetic model and the normalized residuals of the relevant phenotypes as dependent variables in a linear regression analysis. We used 1000 Genomes imputed dosages to represent SNPs identified by both HapMap and 1000 Genomes analyses in STATA. Where 1000 Genomes based dosages were not available we extracted the dosage from the HapMap imputation dataset. We compared the strength of association explained between univariable and multivariable SNP analyses.
Replication and validation
For three of the putative novel associations we attempted to replicate associations in additional data. We used 476 and 529 individuals from the BLSA study [17] to test associations with TNF-alpha and vitamin B12, respectively. In addition, 232, 1554 and 4068 individuals from the TwinsUK study [18] were used to test associations with TNF-alpha, vitamin B12 and chlorine ion levels, respectively.
Data availability
Genome wide summary statistics from all analyses are available from the authors on request. Please contact corresponding authors. 
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